SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-16-012476
Filing Date
2016-03-09
Accepted
2016-03-09 16:31:06
Documents
71
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mrtx-20151231x10k.htm 10-K 1567928
2 EXHIBIT 10.20 mrtx-20151231xex1020.htm EX-10.20 19996
3 EXHIBIT 23.1 mrtx-20151231xex231.htm EX-23.1 12996
4 EXHIBIT 23.2 mrtx-20151231xex232.htm EX-23.2 10846
5 EXHIBIT 31.1 mrtx-20151231xex311.htm EX-31.1 12383
6 EXHIBIT 31.2 mrtx-20151231xex312.htm EX-31.2 13418
7 EXHIBIT 32.1 mrtx-20151231xex321.htm EX-32.1 7902
14 performancegraph01.jpg GRAPHIC 72609
  Complete submission text file 0001628280-16-012476.txt   6937618

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT mrtx-20151231.xml EX-101.INS 1535090
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrtx-20151231.xsd EX-101.SCH 43863
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrtx-20151231_cal.xml EX-101.CAL 69369
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrtx-20151231_def.xml EX-101.DEF 153742
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrtx-20151231_lab.xml EX-101.LAB 601160
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrtx-20151231_pre.xml EX-101.PRE 316858
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35921 | Film No.: 161494928
SIC: 2834 Pharmaceutical Preparations